Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact
NCT05376527
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Oncolytic Virotherapy
Interventions
BIOLOGICAL:
Double Recombinant Vaccinia Virus VV-GMCSF-Lact
Sponsor
"Oncostar" LLC
Collaborators
[object Object]